About NOVOECHO

NOVOECHO is a slimming product produced by Starfield Pharma, with SEMAGLUTIDE as the core ingredient.

The product has passed the consistency evaluation of Novo Nordisk's Smeglutai product (i.e. achieved consistency in quality and efficacy with the product) and holds a Southeast Asian drug registration certificate.

Leading Semaglutide

Semalutide is a new long-acting glucagon like peptide-1 (GLP-1) receptor agonist. As a drug for the treatment of type 2 diabetes and obesity, it has shown significant efficacy in clinical trials.

Smegglutide simulates the action of GLP-1 in nature to promote insulin release and inhibit the secretion of glucagon, thereby reducing blood sugar levels.

The clinical trial results indicate that smeglutide has achieved significant results in reducing patient weight, improving blood sugar control, and reducing cardiovascular risk. Its excellent efficacy makes it one of the important choices for the treatment of type 2 diabetes, and it also shows potential in the treatment of obesity.

Three specifications

Three specifications，Suitable for various groups of peopl

The 3ml version maintains body shape and avoids gaining weight

The 7ml version easily slims down without any burden

The 14ml version has an immediate effect on slimming down

About STARFIELD

Starfield Pharmaceuticals, founded in 1987 and headquartered in Singapore, is a leading pharmaceutical group worldwide. Starfield Pharmaceuticals mainly engages in pharmaceutical business, and also involves multiple fields such as medical devices, cosmetics, medical services, and medical tourism.

Starfield Pharmaceuticals attaches great importance to product research and development, and has established research and development centers in Singapore, the United States, and Switzerland. A total of 149 invention patents have been developed and applied for.

Starfield Pharmaceuticals has 7 subsidiaries worldwide, with a total of 159 approved products sold in 15 countries.

Starfield Pharmaceuticals values social responsibility and contributes to the common development of the global pharmaceutical industry. It has established scholarships at three medical universities, including NUS.

the Certification

Starry Sky Pharmaceutical has advanced factories and facilities designed and constructed strictly in accordance with EU standards, equipped with advanced scientific research equipment, and equipped with a color steel plate purification plant. The pharmaceutical purification air conditioning system supply and return air system ensure a clean production environment

Fully comply with the production management regulations and technical standards of various countries around the world, such as EU GMP, US GMP, and Chinese GMP.